Common Contracts
2 similar Option and License Agreement contracts by Agenus Inc
OPTION AND LICENSE AGREEMENT (AGEN2373) by and between AGENUS INC. and GILEAD SCIENCES, INC. dated as of December 20, 2018Option and License Agreement • March 18th, 2019 • Agenus Inc • Biological products, (no disgnostic substances) • New York
This OPTION AND LICENSE AGREEMENT (this “Agreement”) is entered into as of December 20, 2018 (the “Execution Date”) by and between Agenus Inc., a Delaware corporation (“Agenus”) and Gilead Sciences, Inc., a Delaware corporation (“Gilead”). Agenus and Gilead are each referred to herein by name or as a “Party” or, collectively, as the “Parties.”
OPTION AND LICENSE AGREEMENT (AGEN1223) by and between AGENUS INC. and GILEAD SCIENCES, INC. dated as of December 20, 2018Option and License Agreement • March 18th, 2019 • Agenus Inc • Biological products, (no disgnostic substances) • New York
This OPTION AND LICENSE AGREEMENT (this “Agreement”) is entered into as of December 20, 2018 (the “Execution Date”) by and between Agenus Inc., a Delaware corporation (“Agenus”) and Gilead Sciences, Inc., a Delaware corporation (“Gilead”). Agenus and Gilead are each referred to herein by name or as a “Party” or, collectively, as the “Parties.”
